GE HealthCare introduced Caption AI, an artificial intelligence (AI)-driven software designed for swift cardiac assessments at the point of care on Vscan Air SL. With Caption AI, clinicians utilising Vscan Air SL handheld ultrasound gain access to real-time guidance for capturing high-quality images and automated ejection fraction estimation, aiding clinical decisions across cardiac settings.
Cardiovascular disease (CVD) remains the leading global cause of mortality, with prevalence projected to rise due to population growth and increased longevity. Early detection of heart disease is paramount, yet rapid echocardiographic assessments at the point of care pose challenges in resource-limited facilities and practices. Vscan Air SL with Caption AI aims to overcome these hurdles, enabling healthcare professionals—even non-experts in ultrasound—to efficiently capture cardiac images.
Dr. Jordan B. Strom, a cardiologist, emphasised the transformative impact of innovations like Vscan Air SL with Caption AI in cardiac care, facilitating rapid and confident assessments at the point of care. The AI-guided system offers real-time visual prompts for probe movements and ensures image quality through a built-in quality metre. Additionally, the AutoEF feature calculates left ventricular ejection fraction (LVEF) automatically, streamlining diagnostic processes.
The ultraportable Vscan Air SL boasts exceptional imaging performance, featuring high depth, resolution, and sensitivity with industry-leading single crystal transducer technology. The integration of Caption AI underscores GE HealthCare's commitment to advancing handheld ultrasound, building on the legacy of the pioneering Vscan device introduced in 2010.
Roland Rott, President and CEO of Ultrasound at GE HealthCare, highlighted the strategic significance of integrating Caption AI, acquired through Caption Health in 2023, in strengthening ultrasound capabilities and leadership in the AI landscape. The launch of Vscan Air SL with Caption AI aligns with GE HealthCare's vision of enhancing precision care and marks another milestone in AI-enabled medical devices, with approximately 60 authorizations in the United States, including around 30 ultrasound innovations.
Click here to read the original news story.